← Leaderboards
Richard Yuqi Zhao
Children'S Memorial Hospital (Chicago)
$5,500,626
Attributed
$5,698,438
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $790.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,698,438 · 11
VA$0 · 1
By mechanism
R01$3,238,172 · 4
R21$1,684,125 · 5
RC1$567,190 · 1
R29$208,951 · 1
I01$0 · 1
Top collaborators
- J. Marc Simard5 shared
- Jian Zhang2 shared
Most similar at Children'S Memorial Hospital (Chicago)
Same institution · by research overlap
- Howard Eliot Gendelman$44,946,535
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionViralHiv-1LinkMolecularYeastsPharmaceutical PreparationsCell CycleFda ApprovedViral ProteinsProteinsBaseMediatingLeadGeneticAffectPlayMammalian CellGene MutationVirus ReplicationInsightCell DeathDesign
Grant awards (30)
A Novel Cell-based System for the Search of SARS-CoV-2 ORF3a Inhibitors against COVID-19$194,375
R21 · FY2025 · AI · contact PI
A Novel Cell-based System for the Search of SARS-CoV-2 ORF3a Inhibitors against COVID-19$233,250
R21 · FY2024 · AI · contact PI
Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0
I01 · FY2024 · VA · contact PI
Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0
I01 · FY2023 · VA · contact PI
Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0
I01 · FY2022 · VA · contact PI
Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0
I01 · FY2021 · VA · contact PI
Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity$0
I01 · FY2020 · VA · contact PI
A Novel and High Throughput System for Drug Discovery and Testing on Multidrug Resistant HIV-1 Proteases$301,275
R01 · FY2019 · AI · contact PI
A Novel and High Throughput System for Drug Discovery and Testing on Multidrug Resistant HIV-1 Proteases$301,275
R01 · FY2018 · GM · contact PI
Rapid Phenotyping of the ZIKV Genome$193,125
R21 · FY2018 · AI · contact PI
A Novel and High Throughput System for Drug Discovery and Testing on Multidrug Resistant HIV-1 Proteases$301,275
R01 · FY2017 · GM · contact PI
Rapid Phenotyping of the ZIKV Genome$231,750
R21 · FY2017 · AI · contact PI
Development of Rapid Point-of-Care Tests for Women's Health$567,190
RC1 · FY2010 · AI · contact PI
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle$185,625
R21 · FY2010 · EB
Fission Yeast as a HTS Platform for New Molecular Probes of HIV-1 VPR-Medicated A$37,500
R21 · FY2010 · NS · contact PI
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle$210,000
R21 · FY2009 · EB
Fission Yeast as a HTS Platform for New Molecular Probes of HIV-1 VPR-Medicated A$150,000
R21 · FY2008 · NS · contact PI
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$281,609
R01 · FY2007 · AI · contact PI
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$290,021
R01 · FY2006 · AI · contact PI
Cell Cycle G2/M Pathway Modulated by Viral Protein R$215,690
R01 · FY2006 · GM · contact PI
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$297,000
R01 · FY2005 · AI
Cell Cycle G2/M Pathway Modulated by Viral Protein R$242,855
R01 · FY2004 · GM
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$184,174
R01 · FY2004 · AI
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$96,348
R01 · FY2004 · AI
Cell Cycle G2/M Pathway Modulated by Viral Protein R$250,257
R01 · FY2003 · GM
Effect of HIV-1 Vpr on Basic Cellular Functions (II)$217,416
R01 · FY2003 · AI
Cell Cycle G2/M Pathway Modulated by Viral Protein R$258,977
R01 · FY2002 · GM
Effect of HIV-1 Vpr on Basic Cellular Functions$248,500
R21 · FY2002 · AI
HIV-1 VPR AND BASIC CELLULAR FUNCTIONS$106,524
R29 · FY2001 · AI
HIV-1 VPR AND BASIC CELLULAR FUNCTIONS$102,427
R29 · FY2000 · AI